ACTIVE INGREDIENT
Active Ingredient: Hamamelis Virginiana (Witch Hazel) Water 0.1%
Active Ingredient: Hamamelis Virginiana (Witch Hazel) Water 0.1%
Inactive Ingredients: Water, Butylene Glycol, Glycerin, Niacinamide , Acer saccharum (Sugar Maple) extract, Portulaca Oleracea Extract, 1,2-Hexanediol, Betaine, Chamomilla Recutita (Matricaria) Flower Extract, Arnica Montana Flower Extract, Artemisia Absinthium Extract, Hydroxyethyl acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Hexapeptide-10, Achillea Millefolium Extract, Gentiana Lutea Root Extract, Lactobacillus, Leuconostoc Ferment Filtrate, Cocos Nucifera (Coconut) Fruit Extract, Caprylyl Glycol, Ethylhexylglycerin, Saururus Chinensis Extract, Inonotus Obliquus (Mushroom) Extract, Lentinus Edodes Extract, Phellinus Linteus Extract, Ganoderma Lucidum (Mushroom) Stem Extract, Xanthan Gum, Ledum Palustre Extract, Ecklonia Cava Extract, Artemisia Capillaris Flower Extract, Houttuynia Cordata Extract, Fragrance, Lecithin, Tripeptide-1, Tripeptide-10 Citrulline, Hydrolyzed Soy Protein, Hydrolyzed Wheat Protein, Pseudoalteromonas Ferment Extract,Adenosine Leaders Insolution is formulated by Leaders clinic dermatologists from Seoul National University.
Purpose: Skin Protectant
Warning: For external use only. Avoid contact with eyes. Not for human consumption. Discontinue use if irritation occurs. If irritation persists, consult a physician. Use immediately after opening. Store in cool and dry place. Keep out of reach of children.
KEEP OUT OF REACH OF CHILDREN
Indication and usage: 1. After cleansing and applying toner, attached the upper mask to fit your face shape. 2. Align the center part of the lower mask with the center of your chin and pull the mask up slowly towards your ears. Attached around the ears. 3. Leave on for about 20 minutes and remove both the upper and lower masks. Gently pat your face with fingertips to help the remaining essence to completely absorb into your skin.
Dosage and administration: 2-3 times a week.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69424-190-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-20a6-f424-e053-dadaa90a57ce | b9355023-8e91-4b5a-b93f-c0cb9b07e211 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69424-190-01 | Leaders Mediu 2 Step Double Effect Wrinkle Care Mask | 28 g in 1 CELLO PACK | PATCH | 28 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Witch Hazel | ACTIVE INGREDIENT | 101I4J0U34 | 1 | |
| WITCH HAZEL | ACTIVE MOIETY | 101I4J0U34 | 1 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69424-190 | 69424-190-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Witch Hazel | 101I4J0U34 | ACTIB |
| Water | 059QF0KO0R | IACT |
| Butylene Glycol | 3XUS85K0RA | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c4abd3ab-fddf-4c7f-acf5-e2f2f25e7c5f | b9355023-8e91-4b5a-b93f-c0cb9b07e211 | 2015-04-09 | Warnings | c4abd3ab-fddf-4c7f-acf5-e2f2f25e7c5f b9355023-8e91-4b5a-b93f-c0cb9b07e211 |
Adverse event summaries are temporarily unavailable. Other product information remains available.